Teladoc Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.5 | $2.6 | $2.6 | $2.4 | $2.0 |
| Operating income | -$0.3 | -$1.0 | -$0.2 | -$13.7 | -$0.3 |
| Net income | -$0.2 | -$1.0 | -$0.2 | -$13.7 | -$0.4 |
| Cash Flow Statement | |||||
| Free cash flow | $0.3 | $0.3 | $0.3 | $0.2 | $0.2 |
Shares outstanding 181.7M · Free float 88.2%
Annual filing data through FY ended December 31, 2025; float as of September 10, 2026.